Potential sources of interference with the highly sensitive detection and quantification of alpha‐synuclein seeds by qRT‐QuIC by Ruf, Viktoria C. et al.
Potential sources of interference with the highly sensitive
detection and quantification of alpha-synuclein seeds by
qRT-QuIC
Viktoria C. Ruf1 , Song Shi1, Felix Schmidt2, Daniel Weckbecker2, Georg S. N€ubling3,
Uwe K€odel3, Brit Mollenhauer4,5 and Armin Giese1,2
1 Center for Neuropathology and Prion Research, Ludwig-Maximilians-University, Munich, Germany
2 MODAG GmbH, Wendelsheim, Germany
3 Department of Neurology, University Hospital Munich, Ludwig-Maximilians-University, Munich, Germany
4 Paracelsus-Elena-Klinik, Kassel, Germany
5 University Medical Center, G€ottingen, Germany
Keywords
(q)RT-QuIC; aggregation; alpha-synuclein;
biomarker; Parkinson’s disease; seeding
Correspondence
Viktoria C. Ruf, Center for Neuropathology
and Prion Research, Ludwig-Maximilians-
University Munich, Feodor-Lynen-Str. 23,
D-81377, Munich, Germany
E-mail: viktoria.ruf@med.uni-muenchen.de
(Received 6 November 2019, revised 10
February 2020, accepted 16 March 2020)
doi:10.1002/2211-5463.12844
Parkinson’s disease (PD) is a progressive neurodegenerative disease which
is histologically characterized by loss of dopaminergic neurons in the sub-
stantia nigra and deposition of aggregated alpha-synuclein (aSyn) in the
brain. The detection of aSyn in well accessible fluids has been one of the
central approaches in the development of biomarkers for PD. Recently,
real-time quaking-induced conversion (RT-QuIC) has been successfully
adapted for use with aSyn seeds. Here, we systematically analysed parame-
ters potentially impacting the reliability of this assay by using quantitative
real-time quaking-induced conversion (qRT-QuIC) with in vitro-formed
aSyn seeds. Seeds diluted in cerebrospinal fluid (CSF) accelerated the seed-
ing reaction and slightly increased the sensitivity without affecting speci-
ficity. Repeated freeze–thaw cycles decreased the apparent lag times of
seeds diluted in ddH2O but did not alter the seeding activity of seeds
diluted in CSF. High levels of artificial contamination with blood resulted
in prolonged apparent lag times, while sensitivity and specificity were unaf-
fected. Altogether, qRT-QuIC with aSyn seems to be robust concerning
sensitivity and specificity in our model system, but quantitative interpreta-
tion might be limited under certain conditions.
Parkinson’s disease (PD) is a progressive neurodegenerative
disease which is histologically characterized by loss of
dopaminergic neurons in the substantia nigra and
depositions of aggregated alpha-synuclein (aSyn) in
the brain. First clinical symptoms occur, when 50–
70% of the nigral dopaminergic neurons are already
lost [1–3], which is too late for effective and causative
treatments. Thus, there is an urgent need for reliable
biomarkers, allowing a sensitive and specific diagnosis
in individual patients at an early, ideally pre-symp-
tomatic stage and enabling the monitoring of the dis-
ease progression as well as assessing the efficacy of
therapeutic interventions. As aSyn plays a key role in
PD pathogenesis, the detection of aSyn in easily acces-
sible body fluids like blood, cerebrospinal fluid (CSF)
or saliva has been one of the central approaches in the
development of biomarkers for PD. Several studies
have demonstrated that the levels of total aSyn in CSF
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of PD patients were significantly reduced compared to
healthy controls [4–6]. However, as there exists a sub-
stantial overlap between PD patients and healthy con-
trols on an individual basis, determining total aSyn in
CSF as a single biomarker is presumably not sufficient
to make a definite diagnosis. Attempts to detect patho-
logical forms of aSyn such as phosphorylated aSyn [7]
or aSyn oligomers [8-10] in CSF or blood have so far
not been able to reliably distinguish healthy controls
from patients either. Recently, real-time quaking-in-
duced conversion (RT-QuIC), also referred to as pro-
tein misfolding cyclic amplification by some authors
and initially developed for the ultrasensitive detection
of infectious prions [11,12], has been successfully
adapted for use with aSyn seeds and substrate and rep-
resents so far one of the most promising approaches
[13–16]. The underlying mechanism is based on the con-
version of monomeric substrate protein into b-sheet-rich
aggregates by seeding with minute amounts of protein
aggregates and periodic shaking over several days. The
amplification of protein aggregates is monitored in real-
time by an increase in thioflavin T (ThT) fluorescence.
A further advancement of RT-QuIC was established by
our group with quantitative real-time quaking-induced
conversion (qRT-QuIC). Here, a standard calibration
curve is calculated by quantitative correlation of distinct
amounts of seeds and the apparent lag time, that is the
time until the ThT fluorescence signal starts rising,
which allows conclusions about the quantity of seeds
applied and thus enables the monitoring of the disease
progression and of therapeutic effects in prion-infected
mice [17,18].
For the present study, we have used our qRT-QuIC
assay with in vitro-formed aSyn seeds and substrate to
systematically analyse parameters which in daily prac-
tice potentially interfere with the reliability of the assay.
Materials and methods
Expression and purification of recombinant aSyn
substrate
Expression and purification were performed as previously
described [19,20]. Briefly, the pET5a/aSynuclein (136 TAT)
plasmid (wt-plasmid by Philipp Kahle, LMU Munich; 136-
TAC/TAT-mutation by Matthias Habeck) was transformed
into BL21(DE3) Escherichia coli (New England Biolabs,
Frankfurt am Main, Germany). Protein expression was
induced with 1 M IPTG (Peqlab, Erlangen, Germany) for
4 h at 37 °C. Cells were lysed by boiling after heat inactiva-
tion of proteases. After centrifugation, the supernatant was
filtered through a Filtropur S 0.2 filter (Sarstedt,
N€umbrecht, Germany), loaded onto a 5-mL HiTrap Q HP
anion exchange column (GE Healthcare, Munich, Ger-
many) and eluted over a linear NaCl gradient (25–
500 mM). The fractions containing aSyn were pooled, con-
centrated and gel filtrated via a Superdex 75 prep grade
column (25 mL; GE Healthcare). After adjusting the pro-
tein concentration to 1 mgmL1, aliquots were frozen in
liquid nitrogen and stored at 80 °C until use.
Preparation of in vitro-formed fibrils as seeds
Monomeric aSyn in 50 mM tris pH 7.0 was incubated at a
concentration of 50 µM along with 100 mM NaCl and
0.02% NaN3 in a total volume of 1.4 mL at 37 °C for 96 h
under vigorous orbital shaking (1400 r.p.m.) using an
Eppendorf Thermomixer Comfort (Eppendorf, Hamburg,
Germany) [21]. Fibril formation was confirmed by ThT flu-
orescence, electron microscopy (EM) and sucrose-gradient
centrifugation. After freezing in liquid nitrogen, fibrils were
stored at 80 °C.
ThT Fluorescence measurements
To measure the ThT fluorescence of in vitro-formed fibrils,
fibrils at a concentration of 5 µM were incubated with
50 µM ThT for 5 min at room temperature under constant
stirring. ThT fluorescence spectra (460–560 nm) were subse-
quently recorded at an excitation wavelength of 450 nm
using an LS 55 Luminescence Spectrometer (PerkinElmer,
Waltham, MA, USA).
Electron microscopy
Electron microscopy was carried out as previously
described [21]. Briefly, undiluted fibril samples were applied
onto carbon-coated grids (Science Services, Munich, Ger-
many) and treated with 1–2% uranyl acetate. Microscopy
was performed using a Libra 120 transmission electron
microscope (Carl Zeiss Microscopy GmbH, Oberkochen,
Germany).
Continuous sucrose-gradient centrifugation
For sucrose-gradient centrifugation, solutions containing
50 mM Tris (pH 7.4), 0.1% NP-40 and sucrose (10%, 20%,
30%, 40%, 50% and 60%) were pipetted into a 4-mL
11 9 60 mm polyallomer tube (Beckman Coulter, Brea,
CA, USA) starting with 200 µL of 60% sucrose solution
loaded to the bottom, followed by 400 µL layers of 50–
10% sucrose solution. In vitro-formed fibrils [200 µL at a
concentration of 5 µM (monomer equivalent)] were loaded
on the top of the sucrose gradient. Ultracentrifugation was
performed with 40 000 r.p.m. (163 900 g) at 4 °C for 1 h
using a Sw60Ti rotor (Beckman Coulter). Samples were
harvested after centrifugation from the top to the bottom
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of the sucrose gradient in 200-µL fractions (i.e. fraction 1
represents the top of the gradient, fraction 12 the bottom
fraction). 28 µL of each fraction was used for western blot
analysis. aSyn was detected using an antibody against full-
length aSyn (4B12; BioLegend, San Diego, CA, USA).
Lumbar puncture and CSF handling
All patients provided written informed consent to clinical
assessment and lumbar puncture (LP) in order to collect
CSF according to protocols approved by the local ethics
committees (at University Medical Center Goettingen #36/
7/02 and #9/7/04 and at LMU Munich #523 - 16). All pro-
cedures of this study were in accordance with the 1964 Hel-
sinki declaration and its later amendments or comparable
ethical standards. Diagnostic/therapeutic high-volume LP
was performed in patients with normal pressure hydro-
cephalus (NPH). After the first 2–3 drops were discarded,
30–40 mL CSF was withdrawn and collected into 15-mL
polypropylene tubes. A sample was sent for routine analy-
sis (cell count, total protein, glucose etc.). The remaining
CSF was centrifuged at 2500 g for 10 min at room temper-
ature, subsequently transferred to new tubes and frozen at
80 °C within 30 min.
qRT-QuIC
The qRT-QuIC protocol is based on the protocol previously
described by Shi et al. [17]: for a final reaction volume of
100 µL, 0.1 mgmL1 monomeric aSyn and 10 µM ThT were
pipetted into a black 96-well plate (Thermo Scientific, Wal-
tham, MA, USA) in the presence of 19 QuIC buffer (109
QuIC buffer: 200 mM NaPi, 10 mM EDTA, 1.3 M NaCl pH
6.9). Seeds were diluted in ddH2O or CSF in 0.5-mL Protein
LoBind Tubes (Eppendorf AG) and added at final concen-
trations of 500 nM–500 fM (monomer equivalent), corre-
sponding to 7 9 107–7 9 1013 g of aSyn seeds, to the
seeding reaction. The plate was immediately sealed with
transparent tape (Kisker Biotech, Steinfurt, Deutschland) in
order to avoid cross-contamination and aerosol formation.
Reactions were performed on FLUOstar OPTIMA and
FLUOStar Omega multiwell plate readers (BMG Labtech,
Ortenberg, Germany) at 50 °C for at least 90 h with cycles
of 1 min double-orbital shaking at 600 r.p.m. followed by
1 min of stationary incubation. ThT fluorescence was
recorded every hour using an excitation wavelength of
440 nm and an emission wavelength of 480 nm. Apparent
lag times were determined in a blinded manner and defined
by the last time point before the ThT signal increased com-
pared to the baseline. At least three independent experiments
with duplicates or triplicates per seed concentration were
performed for all different conditions.
For repeated freeze–thaw cycles, three dilution series
(each 500 nM–5 pM) of seeds in ddH2O or CSF were
prepared at a time and 0, 1 or 5 times frozen in liquid
nitrogen and subsequently thawed at room temperature. Of
note, always the whole dilution series with all subsequent
dilutions were subjected to the number of freeze–thaw
cycles indicated.
To mimic contamination with blood, blood by courtesy
of two healthy volunteers [volunteer 1: sex: F, age: 30–35,
red blood cell count (RBC): 4.6 9 106 per µL; volunteer 2:
sex: M, age: 30–35, RBC: 5.2 9 106 per µL], of whom ver-
bal informed consent was obtained, was collected into unla-
belled EDTA-coated test tubes (EDTA K3 S-Monovette
H€amatologie 2.6 mL; Sarstedt). Subsequently, the whole
blood sample was diluted in CSF to the number of RBC
indicated and the prepared CSF samples were spiked with
aSyn seeds as specified above. All procedures of this study
were in accordance with the 1964 Helsinki declaration and
its later amendments or comparable ethical standards.
Results
Characterization of in vitro-formed seeds
To adapt qRT-QuIC for use with aSyn seeds and to
optimize the assay conditions, we used artificial, in vitro-
aggregated aSyn as seeds to provide standardized condi-
tions with low interexperimental variation and to save
precious and irretrievable patient samples. aSyn seeds
were prepared by incubating monomeric aSyn at a con-
centration of 50 µM for 96 h at 37 °C under vigorous
orbital shaking at 1400 r.p.m. ThT fluorescence mea-
surements of the seed preparations obtained showed an
increased fluorescence intensity compared to buffer
(baseline) or aSyn monomer (Fig. 1A), indicating that
the in vitro-formed seed preparations consist at least in
part of amyloid fibrils which could be confirmed by EM
(Fig. 1B). To retrieve more information about the size
of the aggregates present, we performed sucrose-gradient
centrifugation, where we observed a continuous distribu-
tion of aSyn aggregates of different sizes peaking in
fractions 7–9 (Fig. 1C).
Adaptation of qRT-QuIC for use with aSyn seeds
and substrate
Based on the protocol described by Shi et al. [17],
which had been optimized for the ultrasensitive detec-
tion of minute amounts of pathological prion protein,
we adapted the assay conditions for the use with aSyn
seeds. We found that a substrate concentration of
0.1 mgmL1 was ideal to reliably detect amounts of
aSyn seeds as low as 7 9 1012 g (monomer equiva-
lent) (Fig. 2A) without self-aggregation of the sub-
strate within the observation time. Increasing the
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reaction temperature from 37 to 50 °C strongly accel-
erated the seeding reaction (Fig. S1). Shaking condi-
tions were maintained according to Shi et al. [17]:
1 min double-orbital shaking at 600 r.p.m. followed
by 1 min of stationary incubation with recording of
ThT fluorescence every hour. Quantitative analysis of
the apparent lag times revealed an exponential correla-
tion between the amount of seeds applied and the
apparent lag time (Fig. 2B).
To see if and to what extent particular pre-treat-
ments of the seed preparations might affect their seed-
ing activity, single experiments were performed where
the seed preparation was ultracentrifuged with
47 000 r.p.m. (135 800 g) at 20 °C for 30 min to possi-
bly increase the concentration of active seeds or where
the seed preparation was sonicated to receive a more
homogeneous seed population (Fig. S2). However, as
there were no obvious differences in the seeding activ-
ity after ultracentrifugation or sonication compared to
conditions without pre-treatment, we decided to use
the seed preparations without further processing.
CSF matrix does not inhibit but slightly increases
the rate of aggregation induced by artificial
seeds
Cerebrospinal fluid consists of a variety of different
components such as proteins, especially albumin,
electrolytes, glucose and small amounts of cells. All
these factors potentially interfere with the seeding reac-
tion. As it is very difficult to artificially mimic the
complex composition of CSF, we spiked CSF from
patients with NPH, from which high volumes of CSF
were obtained, with in vitro-formed aSyn seeds and
performed qRT-QuIC to analyse, in what way the
CSF matrix would affect the aggregation process.
When seeds were diluted in CSF, we found a marked
decrease of the apparent lag times compared to seeds
diluted in ddH2O (Fig. 3A), while there was still an
exponential correlation between the amount of seeds
and lag times (Fig. 3B). Moreover, we reliably
observed a seeding reaction with 7 9 1013 g aSyn
seeds, indicating a slightly increased sensitivity of the
assay with seeds diluted in CSF. However, for reasons
of practicability, all subsequent experiments were per-
formed with 7 9 1012 g aSyn seed as the lowest
amount of seeds.
Freeze–thaw cycles do not affect the seeding
activity of seeds diluted in CSF but reduce the
apparent lag time of seeds diluted in ddH2O
In clinical routine, analyses of patient samples are usu-
ally performed in a sequential, stepwise process; thus,
patient samples may undergo several freeze–thaw
cycles until a particular test is performed. As this
Fig. 1. Characterization of in vitro-formed
seeds. (A) Compared to monomeric aSyn
or buffer (baseline), the aSyn seed
preparation shows a strong ThT
fluorescence signal indicating formation of
amyloid fibrils which was (B) further
confirmed by EM; scale bar 100 nm. (C)
Sucrose-gradient centrifugation depicts a
continuous distribution of differently sized
aSyn aggregates over all fractions with a
peak in fractions 7–9.
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might have an impact on the seeding properties of the
seeds in CSF samples, we tried to assess the seeding
activity of in vitro-formed seeds after one and five
freeze–thaw cycles compared to seeds without freezing
and thawing. When seeds were diluted in ddH2O, a
strong decrease of the lag times especially at lower
seed concentrations could be observed with only one
freeze–thaw cycle. After five freeze–thaw cycles, this
effect was even more pronounced (Fig. 4A). However,
for seeds diluted in CSF, no differences between seeds
with and without freeze–thaw cycles could be detected
(Fig. 4B).
Contamination with blood does not interfere
with sensitivity or specificity of qRT-QuIC but
leads to increased apparent lag times
A common problem for the analysis of CSF samples is
contamination with blood either during LP or due to
previous bleeding into CSF spaces, for example
Fig. 2. Adapting qRT-QuIC for aSyn seeds. (A) Monomeric aSyn at a concentration of 0.1 mgmL1 was used as substrate and decreasing
amounts of in vitro-formed seeds were added to the reaction. A reliable ThT fluorescence signal was detected for seed amounts as low as
7 9 1012 g. For 7 9 1013 g of aSyn seeds, no signal could be detected by qRT-QuIC anymore. (B) With decreasing amounts of seeds,
the apparent lag times increased in an exponential manner. Each single grey dot represents the mean of one independent experiment
(n = 4), and black dots represent the mean of the four independent experiments; error bars indicate SEM.
Fig. 3. CSF matrix does not inhibit aggregation of in vitro-formed seeds. (A) With aSyn seeds spiked in CSF, the apparent lag times were
slightly shorter compared to the same amounts of aSyn seeds diluted in ddH2O. However, the aggregation per se was not impaired and
showed as well an exponential association between the amount of applied seeds and apparent lag time (B). Each single grey dot represents
the mean of one independent experiment (n = 4), and black dots represent the mean of the four independent experiments; error bars
indicate SEM.
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following craniocerebral injury after falling. Thus, we
sought to investigate to what extent contamination
with blood might interfere with the seeding reaction in
a qualitative and quantitative manner. Therefore,
whole blood from healthy volunteers (assuming an
average RBC count of 5 000 000 RBC per µL) was
diluted to final concentrations of 1000, 100 and
10 RBC per µL in the CSF sample to be analysed.
While with 1000 RBC per µL a discrete reddish dis-
colouration was still visible, admixtures of 100 or
10 RBC per µL could not be detected by eye anymore.
Increasing blood concentrations led to a nearly parallel
increase of the apparent lag times for all amounts of
seeds tested, with an average increase of 2.3 h at
10 RBC per µL (Fig. 5A), 5.3 h at 100 RBC per µL
(Fig. 5B) and 7.2 h at 1000 RBC per µL compared to
0 RBC per µL (Fig. 5C). Regarding sensitivity and
specificity, no differences could be observed between
different blood concentrations: Amounts of seeds as
low as 7 9 1012 g were able to induce a significant
increase in ThT fluorescence, while the rate of false-
positive reactions was not increased in samples with
artificial contamination with blood.
Discussion
Neurodegenerative diseases like Alzheimer’s and
Parkinson’s disease have become a growing problem
in our ageing population, as no causal and only lim-
ited symptomatic therapy is available to date. To pro-
vide effective and causative treatment strategies, an
early and reliable diagnosis of specific neurodegenera-
tive disease entities is required. Various approaches to
develop sensitive and specific biomarkers to diagnose
synucleinopathies or other neurodegenerative diseases
have been followed, of which qRT-QuIC seems cur-
rently to be one of the most promising approaches.
We and others have adapted qRT-QuIC for the use
with aSyn seeds and substrate. In this study, we have
systematically characterized factors of daily routine,
which potentially interfere with the reliability of the
assay.
To adapt qRT-QuIC for use with aSyn seeds and
substrate, we used in vitro-formed aSyn seeds, which
we characterized by ThT fluorescence measurements,
continuous sucrose-gradient centrifugation, and EM.
ThT fluorescence measurements revealed strong fluo-
rescence intensities for the seed preparations compared
to buffer or monomeric protein, indicating the pres-
ence of amyloid fibrils, which could be confirmed by
EM. Using sucrose-gradient centrifugation, we could
demonstrate a continuous size distribution suggesting
that the seed preparation contains a variety of differ-
ent-sized aggregates. To address the question, if it was
possible to enrich the fraction of active seeds or to
retrieve a more homogenous seed population, single
Fig. 4. Freeze–thaw cycles accelerate the seeding reaction when seeds are diluted in ddH2O but have no effect on seeds diluted in CSF.
Seeds diluted in either ddH2O or CSF at the concentrations indicated were subjected to 0, 1 or 5 freeze–thaw cycles immediately prior to
being applied for the experiment. While a clear difference in apparent lag times was detected for seeds diluted in ddH2O (A), no obvious
difference could be observed after 1 or 5 freeze–thaw cycles when CSF was spiked with aSyn seeds (B). Single dots represent the mean of
n = 3 independent experiments; error bars indicate SEM.
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experiments were performed, where the seed prepara-
tion was ultracentrifuged or sonicated. However, we
could not find obvious differences of the seeding activ-
ity compared to unprocessed seed preparations. More-
over, as it is unclear which particular aggregate species
in fact trigger the seeding reaction and as there possi-
bly exists a spectrum of different aggregate species in
patient brains and CSF, we decided to proceed with-
out further processing of the seed preparations.
To adapt qRT-QuIC for use with aSyn seeds and
substrate, we diluted the seed preparations by factors
of ten in ddH2O, thus, reaching absolute amounts of
7 9 107–7 9 1013 g of aSyn seeds, corresponding to
concentrations of 500 nM–500 fM of aSyn seeds in the
final reaction. A reaction temperature of 50 °C was
chosen, as the seeding reaction seems to be reasonably
fast. Moreover, at this temperature, microbial growth
is virtually avoided, while at the same time there is no
Fig. 5. Contamination with blood prolongs apparent lag times. To mimic contamination with blood, whole blood of healthy volunteers was
diluted to an estimated RBC of 1000, 100 and 10 RBC per µL, respectively, in CSF, which was spiked with aSyn seeds at the amounts
indicated. (A) No obvious differences regarding apparent lag times could be detected with 10 RBC per µL. (B) With 100 RBC per µL,
apparent lag times slightly and (C) with 1000 RBC per µL clearly increased in a comparable manner for all amounts of aSyn seeds tested.
Each single dot represents the mean of n = 4 independent experiments; error bars indicate SEM.
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risk of protein denaturation yet. However, homoge-
neous heating of the multiwell plate should be ensured,
and plates should be densely sealed to prevent evapo-
ration. Decreasing seed concentrations led to increas-
ing apparent lag times, which are correlated by an
exponential relationship. This was used to establish a
standard calibration curve.
As CSF is a body fluid of complex composition, we
wanted to ensure that the CSF matrix per se does not
impair the seeding reaction. Therefore, we spiked CSF
with in vitro-formed seeds and performed qRT-QuIC
under the same conditions as described before. In contrast
to seeds diluted in ddH2O, we reliably observed seeding
activity at 7 9 1013 g aSyn seed. The lag times were gen-
erally shorter, especially at lower seed concentrations.
Specificity was not affected. A possible explanation for
the more sensitive and faster reaction could be that the
functional seed concentration is increased, as the addi-
tional proteins from CSF might prevent the adsorption of
seeds to the walls of the wells. Assuming a normal CSF
protein concentration of 1.5–4.5 mgmL1, the concen-
tration of protein in the reaction well would be at least
doubled compared to our experiments with seeds diluted
in ddH2O, where the aSyn substrate displays the only
considerable protein source.
As clinical diagnostics is typically a sequential, multi-
step process, it is inevitable to store samples refrigerated
or frozen over certain time periods and thaw them again
for subsequent analyses. Thus, we tested the seeding
activity of the in vitro-formed seeds after one and five
freeze–thaw cycles. While there was no obvious differ-
ence for CSF spiked with seeds, already one freeze–thaw
cycle of seeds diluted in ddH2O was associated with a
remarkable reduction of the apparent lag times, espe-
cially at lower seed concentrations. A potential explana-
tion for this could be an increased fractionation of seeds
diluted in ddH2O leading to a higher functional concen-
tration of seeds (while the protein concentration remains
the same) and thus to a reduction of the apparent lag
phases. In contrast, seeds diluted in CSF might be pro-
tected against fragmentation due to the composition of
CSF so that the functional concentration of seeds would
not change. This hypothesis is supported by the observa-
tion that the ThT fluorescence of seeds diluted in ddH2O
is clearly reduced after one or five freeze–thaw cycles,
whereas only a slight reduction of the ThT fluorescence
was recorded for seeds diluted in CSF (Fig. S3). In addi-
tion, it might be possible that seeds diluted in ddH2O
undergo structural alterations during freeze–thaw cycles
resulting in a different seeding activity. As we have
observed changes in the apparent lag phases only with
seeds diluted in ddH2O but not with seeds diluted in
CSF, we assume that repeated freezing and thawing of
CSF samples will most likely not substantially affect the
activity of the seeds present in CSF. Therefore, we did
not further follow up our observations on seeds diluted
in ddH2O. Contamination of CSF samples with blood is
commonly observed in daily routine and might interfere
with the seeding reaction leading to erroneous results. To
analyse the impact of contamination with blood, we
mimicked contamination with blood by diluting whole
blood of two healthy volunteers in CSF to estimated con-
centrations of 1000, 100 and 10 RBC per µL, respec-
tively. While at 1000 RBC per µL, a discretely reddish
discolouring of the CSF sample could still be observed
by eye, CSF samples with 100 or 10 RBC per µL showed
no visible discolouring. Increasing RBC counts caused a
similar prolongation of the apparent lag times for all
amounts of seeds tested leading to a nearly parallel shift
of the calibration curve towards prolonged lag times.
While the average delay was with 2.3 h comparably small
for 10 vs 0 RBC per µL, lager differences of 5.3 and
7.2 h were detected for 100 and 1000 RBC per µL,
respectively, so that especially the delay of the lag times
at 1000 RBC per µL would lead to a considerable under-
estimation of the amount of seeds. However, sensitivity
and specificity of the assay were not affected by any
extent of artificial contamination with blood. About the
reasons for the prolonged lag times we can only specu-
late: as it is well known that blood and particularly ery-
throcytes [22–24] contain high levels of aSyn, blood-
derived aSyn might have a relevant impact on the aggre-
gation assay. Assuming a concentration of around
25 000 ngmL1 aSyn in blood [23], the maximum con-
centration of blood-derived aSyn in our assay would be
0.5 ngmL1 and, thus, negligible given the substrate
concentration of 0.1 mgmL1 aSyn. Therefore, it seems
unlikely that blood-derived aSyn has a significant impact
on the aggregation reaction. Moreover, one would prob-
ably expect a decrease in lag times with higher amounts
of aSyn in contrast to the observed increase. Another fac-
tor that needs to be considered is serum albumin, the
most abundant protein in blood and known to inhibit
the aggregation of various amyloidogenic proteins such
as aSyn [25–27]. However, with an average albumin con-
centration of 3.5–5 gL1 in blood, the maximum con-
centration of blood-derived albumin in the reaction
volume would be between 0.07 and 0.1 mgL1, whereas
the amount of CSF-derived albumin is between 3 and
5 mgL1, so that the additional blood-derived albumin
should not play a major role for the seeding reaction. As
the samples are incubated under comparably unphysio-
logical conditions (pH 6.9, 50 °C and vigorous shaking),
the blood cells are presumably quickly damaged leading
to release of intracellular components or membrane frag-
ments, which may contribute to the altered aggregation
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behaviour. Finally, it is very likely that not only one sin-
gle factor, but several factors together contribute to the
prolonged lag times observed. Based on our observa-
tions, we would recommend to carefully interpret the
qRT-QuIC results of CSF samples with visible contami-
nation with blood in terms of quantitative aspects.
In this study, we show for the first time that the
qRT-QuIC seeding reaction is altered – particularly
regarding quantitative aspects – under conditions,
which are relevant in handling of clinical samples. The
strength of our model with artificial seeds is that we
can systematically and easily vary different parameters
like freeze–thaw cycles and blood contamination and
analyse their effects at different and defined amounts
of seeds. However, one must be cautious with transfer-
ring the results one-to-one to real patient-derived CSF
samples. Nevertheless, the results of this study address
an important aspect and represent a reasonable and
solid basis for further considerations and investigations
with real patient-derived CSF specimens.
Conclusions
With regard to clinical practicability and handling of
CSF samples, we have used our model system and sys-
tematically characterized parameters which potentially
interfere with the seeding reaction and thus lead to
false-positive or false-negative results. Altogether,
qRT-QuIC turned out to be quite a robust assay in
terms of sensitivity and specificity although quantita-
tive interpretation, for example, in terms of disease
progression or therapy monitoring might be impaired
under certain conditions. Thus, explicit requirements
to the quality of CSF samples would need to be
defined. Although our findings still need to be con-
firmed using patient-derived CSF samples, they pro-
vide a good starting point for further investigations.
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Fig. S1. Higher temperatures decrease apparent lag
times. Compared to 50 °C (Fig. 2A), the seeding reac-
tion is much slower at 37 °C.
Fig. S2. Different pre-treatments of the seed prepara-
tion have no effect on their seeding activity.
892 FEBS Open Bio 10 (2020) 883–893 ª 2020 The Authors. Published by FEBS Press and John Wiley & Sons Ltd.
Sources of interference with a-Syn qRT-QuIC V. C. Ruf et al.
Ultracentrifugation (A) or sonication (B) of the seed
preparation does not alter the seeding activity of the
seed preparation. Error bars indicate standard devia-
tion; n = 1.
Fig. S3. Multiple freeze–thaw cycles reduce ThT fluo-
rescence of seeds diluted in ddH2O but not of seeds
diluted in CSF. Seeds diluted in either ddH2O or CSF
were subjected to 0, 1, or 5 freeze–thaw cycles before
being added to the seeding reaction. Diagrams depict
the baseline fluorescence at the beginning of the seed-
ing reaction at a seed concentration of 500 nM, where
a clear decrease of the ThT fluorescence is observed
for seeds diluted in ddH2O but only a slight reduction
of ThT fluorescence can be seen after five freeze–thaw
cycles. Error bars indicate standard error of means;
n = 3.
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